Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I will attend the show in Israel. I will try to share the presentation from there
Just hold !
Hi Big Fred. First the seedo deal. CNBX will get royalties 2019 of min $500000 to a max of $ 8 Million dollars.
With Pre orders of 3500 units this is achievable
Wanna caps license expires soon. So I'm sure they are working on a new deal with a larger company that will market the SR pills in Canada and US on a larger scale.
Big Fred they have a royalty agreement, CNBX will see revenues from this
Stole my words... let's go CNBX !
Great to see the CEO meeting with the media
https://www.linkedin.com/feed/update/urn:li:activity:6437369301782523904
As amalgamation seems to be driving SP It looks like CNBX is gaining traction after the news from last week
Why don't you look at it as a revenue stream to fund research and expand on patient data .
Link to interview BNN Bloomberg
http://www.bnnbloomberg.ca/video/firms-team-up-to-create-medical-cannabis-auto-grow-device~1463872
Hey Jim
Relax
The shows are still on. Today the CEO had an interview on Bloomberg TV . The news is getting out.
Easy answer 5MM in orders.
All coiled up and ready to go ....
Follow cannabics Pharmaceuticals on Linkedln .
https://hempindustrydaily.com/open-up-the-floodgates-fda-approval-signals-further-cbd-investment/
I think this is the bottom. Way oversold. Usually this will run up over next few weeks
Hi Jim. I talked with him regarding PR. They are working on it. I did get a picture of him at the show.
Last week.
I was at the San Jose show and met the CEO. Lots of good things to come. PR will improve
Terry_H I do not agree with your conclusion. If you did some research on this company you would see the potential. Between their IP, patents , clinical studies, lab and collaborations with German and other companies.
This company is just starting to make progress in personal diagnosis, formulation and monitoring of cancer.
From an economic stand. The company has no debt, a small float on the market.
I know it will be a leader in cannabis cancer diagnosis and formulations.
This will soar with the news or they will be taken over by pharmaceutical company.
I am holding over 200K shares long !
Check out quarterly report issued today. Great vision looking forward !
Should be interesting tomorrow !